Experience
Kaken Pharmaceutical Co., Ltd.
Zydus Pharmaceuticals (USA) Inc.
Represents Kaken in patent infringement litigation concerning multiple ANDAs for generic versions of Jublia.
Kaken Pharmaceutical Co., Ltd. v. Zydus Pharmaceuticals (USA) Inc., 3:18-cv-13635, D.N.J., Judges Sheridan, Goodman
Amarin Pharms. Ireland Ltd. v. Omthera Pharms., Inc.
Omthera Pharmaceuticals, Inc.; AstraZeneca Pharmaceuticals LP
BTG Inc., Ltd v. Actavis Labs FL Inc.; Amneal Pharms LLC
BTG Inc., Ltd.
Valeant Pharmaceuticals NA, LLC v. Zydus Pharmaceuticals, Inc.
Valeant Pharmaceuticals NA, LLC
Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, Inc.
Otsuka Pharmaceutical Co.
Medicis Pharmaceutical Corp. v. Zydus Pharmaceuticals (USA) Inc.
Medicis Pharmaceutical Corp.
Finnegan revives key Jublia® patent at the Federal Circuit
Kaken Pharmaceutical Co., Ltd.; Bausch Health Care
Valeant Pharmaceuticals North America, LLC v. Actavis, Inc.
Valeant Pharmaceuticals North America, LLC
Mitsubishi Tanabe Pharma Corporation v. Shanghai Auzone Biological Technology Co., Ltd et al.
Mitsubishi Tanabe Pharma Corporation
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.